AFfirm™ mAb
AFfirm antibodies are mouse monoclonal antibodies developed by Affinity™ with independent patents, new production process, higher antibody specificity and excellent stability between batches.
Why AFfirm™ mAb from Affinity?
| Catalog | Product | Source | Clonality | Clone Number | Reactivity | Application | Citations |
|---|---|---|---|---|---|---|---|
| BF9608 | AFfirm™ HSPA2 mAb | Mouse | Monoclonal | AFfirm9608 | Human | WB | 0 |
| BF9609 | AFfirm™ TLS/FUS mAb | Mouse | Monoclonal | AFfirm9609 | Human | WB | 0 |
| BF9610 | AFfirm™ ARL11 mAb | Mouse | Monoclonal | AFfirm9610 | Human,Rat | WB | 0 |
| BF9611 | AFfirm™ ARL4A mAb | Mouse | Monoclonal | AFfirm9611 | Human,Mouse | WB | 0 |
| BF9612 | AFfirm™ RTCD1 mAb | Mouse | Monoclonal | AFfirm9612 | Human,Rat | WB | 0 |
| BF9613 | AFfirm™ TAAR5 mAb | Mouse | Monoclonal | AFfirm9613 | Human,Mouse | WB | 0 |
| BF9614 | AFfirm™ MANS1 mAb | Mouse | Monoclonal | AFfirm9614 | Human | WB | 0 |
| BF9615 | AFfirm™ RAB6C mAb | Mouse | Monoclonal | AFfirm9615 | Human,Rat | WB | 0 |
| BF9616 | AFfirm™ NMDA epsilon 3 mAb | Mouse | Monoclonal | AFfirm9616 | Human | WB | 0 |
| BF9617 | AFfirm™ MRPL47 mAb | Mouse | Monoclonal | AFfirm9617 | Human | WB | 0 |
| BF9618 | AFfirm™ EF-Tu mAb | Mouse | Monoclonal | AFfirm9618 | Human | WB | 0 |
| BF9619 | AFfirm™ RBBP7 mAb | Mouse | Monoclonal | AFfirm9619 | Human | WB | 0 |
| BF9620 | AFfirm™ FGFP1 mAb | Mouse | Monoclonal | AFfirm9620 | Human | WB | 0 |
| BF9621 | AFfirm™ SERPINA11 mAb | Mouse | Monoclonal | AFfirm9621 | Human | WB | 0 |
| BF9622 | AFfirm™ MAP4K5 mAb | Mouse | Monoclonal | AFfirm9622 | Human | WB | 0 |
| BF9623 | AFfirm™ SH2B2 mAb | Mouse | Monoclonal | AFfirm9623 | Human | WB | 0 |
| BF9624 | AFfirm™ ALDH3B2 mAb | Mouse | Monoclonal | AFfirm9624 | Human | WB | 0 |
| BF9625 | AFfirm™ Synphilin-1 mAb | Mouse | Monoclonal | AFfirm9625 | Human | WB | 0 |
| BF9626 | AFfirm™ HDLBP mAb | Mouse | Monoclonal | AFfirm9626 | Human | WB | 0 |
| BF9627 | AFfirm™ HSP74 mAb | Mouse | Monoclonal | AFfirm9627 | Human | WB | 0 |